SEC Form 5 · accession 0001203311-17-000008
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2016 | G | 1,600 | $65.09 | D | 637,235 | D | |
| Common Stock | Dec 16, 2016 | G | 800 | $62.61 | D | 636,435 | D |
Table II — derivative securities
No Table II lines on this filing.